Wellnex LifeASX:WNX -2.13% EBIT per Share is A$-0.26 as of Dec. 2025. The stock has 2 warning signs investors should review. Among 1,581 Consumer Packaged Goods companies, Wellnex Life ranks better than 71.54% on this metric.
Wellnex Life's EBIT per Share for the
six
months ended in Dec. 2025 was A$-0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.26.
During the past 3 years, the average EBIT per Share Growth Rate was 22.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 39.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Wellnex Life's EBIT per Share or its related term are showing as below:
ASX:WNX'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -41.6 Med: 28.25 Max: 48.2
Current: 22.6
During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Wellnex Life was 48.20% per year. The lowest was -41.60% per year. And the median was 28.25% per year.
ASX:WNX's 3-Year EBIT Growth Rate is ranked better than 71.54% of 1581
companies
in the Consumer Packaged Goods industry
Industry Median: 6.9
vs ASX:WNX: 22.60
Wellnex Life's EBIT for the
six
months ended in Dec. 2025 was A$-1.14 Mil.
Wellnex Life (ASX:WNX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Wellnex Life EBIT per Share Related Terms
Wellnex Life EBIT per Share Historical Data
* Premium members only.
The historical data trend for Wellnex Life's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.26
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellnex Life (ASX:WNX) has a EBIT per Share of A$-0.26 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Wellnex Life and its competitors. According to the industry distribution chart, Wellnex Life ranks #450 out of 1581 companies in the Consumer Packaged Goods industry, placing it in the top 28.5%.
Is Wellnex Life's EBIT per Share too high?
Wellnex Life's current EBIT per Share is A$-0.26. Based on the distribution chart, Wellnex Life ranks #450 out of 1581 companies in the Consumer Packaged Goods industry, which is above the industry midpoint.
How does Wellnex Life's EBIT per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Wellnex Life ranks #450 out of 1581 companies for EBIT per Share. This puts Wellnex Life in the upper half of its industry. The industry median EBIT per Share is 6.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Consumer Packaged Goods company?
The median EBIT per Share among Consumer Packaged Goods companies is 6.90, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Wellnex Life and its competitors. For the Consumer Packaged Goods industry, the median EBIT per Share is 6.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellnex Life's current EBIT per Share is A$-0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (ASX:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.34, compared to a current price of A$0.05 — trading 86.5% below its estimated fair value. The current EBIT per Share is A$-0.26. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Wellnex Life (ASX:WNX), the current EBIT per Share is A$-0.26 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:WNX has been successfully added to your 